Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies

IF 8.7 2区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Isabella Lurje , Nadine T. Gaisa , Ralf Weiskirchen , Frank Tacke
{"title":"Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies","authors":"Isabella Lurje ,&nbsp;Nadine T. Gaisa ,&nbsp;Ralf Weiskirchen ,&nbsp;Frank Tacke","doi":"10.1016/j.mam.2023.101191","DOIUrl":null,"url":null,"abstract":"<div><p>Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological wound healing response and can occur in various organs such as the heart, lung, liver, kidney, skin, and bone marrow. Organ fibrosis significantly contributes to global morbidity and mortality. A broad spectrum of etiologies can cause fibrosis, including acute and chronic ischemia, hypertension, chronic viral infection (e.g., viral hepatitis), environmental exposure (e.g., pneumoconiosis, alcohol, nutrition, smoking) and genetic diseases (e.g., cystic fibrosis, alpha-1-antitrypsin deficiency). Common mechanisms across organs and disease etiologies involve a sustained injury to parenchymal cells that triggers a wound healing response, which becomes deregulated in the disease process. A transformation of resting fibroblasts into myofibroblasts with excessive extracellular matrix production constitutes the hallmark of disease, however, multiple other cell types such as immune cells, predominantly monocytes/macrophages, endothelial cells, and parenchymal cells form a complex network of profibrotic cellular crosstalk. Across organs, leading mediators include growth factors like transforming growth factor-β and platelet-derived growth factor, cytokines like interleukin-10, interleukin-13, interleukin-17, and danger-associated molecular patterns. More recently, insights into fibrosis regression and resolution of chronic conditions have deepened our understanding of beneficial, protective effects of immune cells, soluble mediators and intracellular signaling. Further in-depth insights into the mechanisms of fibrogenesis can provide the rationale for therapeutic interventions and the development of targeted antifibrotic agents. This review gives insight into shared responses and cellular mechanisms across organs and etiologies, aiming to paint a comprehensive picture of fibrotic diseases in both experimental settings and in human pathology.</p></div>","PeriodicalId":49798,"journal":{"name":"Molecular Aspects of Medicine","volume":null,"pages":null},"PeriodicalIF":8.7000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Aspects of Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0098299723000316","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 8

Abstract

Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological wound healing response and can occur in various organs such as the heart, lung, liver, kidney, skin, and bone marrow. Organ fibrosis significantly contributes to global morbidity and mortality. A broad spectrum of etiologies can cause fibrosis, including acute and chronic ischemia, hypertension, chronic viral infection (e.g., viral hepatitis), environmental exposure (e.g., pneumoconiosis, alcohol, nutrition, smoking) and genetic diseases (e.g., cystic fibrosis, alpha-1-antitrypsin deficiency). Common mechanisms across organs and disease etiologies involve a sustained injury to parenchymal cells that triggers a wound healing response, which becomes deregulated in the disease process. A transformation of resting fibroblasts into myofibroblasts with excessive extracellular matrix production constitutes the hallmark of disease, however, multiple other cell types such as immune cells, predominantly monocytes/macrophages, endothelial cells, and parenchymal cells form a complex network of profibrotic cellular crosstalk. Across organs, leading mediators include growth factors like transforming growth factor-β and platelet-derived growth factor, cytokines like interleukin-10, interleukin-13, interleukin-17, and danger-associated molecular patterns. More recently, insights into fibrosis regression and resolution of chronic conditions have deepened our understanding of beneficial, protective effects of immune cells, soluble mediators and intracellular signaling. Further in-depth insights into the mechanisms of fibrogenesis can provide the rationale for therapeutic interventions and the development of targeted antifibrotic agents. This review gives insight into shared responses and cellular mechanisms across organs and etiologies, aiming to paint a comprehensive picture of fibrotic diseases in both experimental settings and in human pathology.

器官纤维化的机制:新出现的概念和新治疗策略的意义
纤维化或组织瘢痕形成是一种与生理伤口愈合反应的病理偏离,可发生在心脏、肺、肝、肾、皮肤和骨髓等各种器官。器官纤维化对全球发病率和死亡率有重要影响。广泛的病因可导致纤维化,包括急性和慢性缺血、高血压、慢性病毒感染(如病毒性肝炎)、环境暴露(如肺尘埃沉着病、酒精、营养、吸烟)和遗传疾病(如囊性纤维化、α-1-抗胰蛋白酶缺乏症)。跨器官和疾病病因的常见机制包括对实质细胞的持续损伤,从而触发伤口愈合反应,而伤口愈合反应在疾病过程中变得不受控制。静息成纤维细胞转化为细胞外基质产生过多的肌成纤维细胞是疾病的标志,然而,多种其他细胞类型,如免疫细胞,主要是单核细胞/巨噬细胞、内皮细胞和实质细胞,形成了促纤维化细胞串扰的复杂网络。在各个器官中,主要介质包括生长因子,如转化生长因子-β和血小板衍生生长因子,细胞因子,如白细胞介素-10、白细胞介蛋白-13、白细胞素-17,以及危险相关分子模式。最近,对慢性疾病的纤维化消退和解决的深入了解加深了我们对免疫细胞、可溶性介质和细胞内信号的有益保护作用的理解。对纤维化发生机制的进一步深入了解可以为治疗干预和靶向抗纤维化药物的开发提供依据。这篇综述深入了解了不同器官和病因的共同反应和细胞机制,旨在全面了解实验环境和人类病理学中的纤维化疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Aspects of Medicine
Molecular Aspects of Medicine 医学-生化与分子生物学
CiteScore
18.20
自引率
0.00%
发文量
85
审稿时长
55 days
期刊介绍: Molecular Aspects of Medicine is a review journal that serves as an official publication of the International Union of Biochemistry and Molecular Biology. It caters to physicians and biomedical scientists and aims to bridge the gap between these two fields. The journal encourages practicing clinical scientists to contribute by providing extended reviews on the molecular aspects of a specific medical field. These articles are written in a way that appeals to both doctors who may struggle with basic science and basic scientists who may have limited awareness of clinical practice issues. The journal covers a wide range of medical topics to showcase the molecular insights gained from basic science and highlight the challenging problems that medicine presents to the scientific community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信